20
Chongqing Huapont Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is RUXOLITINIB PHOSPHATE, with a corresponding US DMF Number 29480.
Remarkably, this DMF maintains an Active status since its submission on May 29, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 16, 2015, and payment made on July 31, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II